PURPOSE Retrospective analyses of patients with stage I-II thymic epithelial tumors (TET) who were treated with either surgery alone (S) or surgery plus postoperative radiation therapy (SRT) were conducted to evaluate the role of adjuvant radiation therapy (RT). MATERIALS AND METHODS A total of 110 stage I-II TET patients following complete resection were included in this study. Postoperative radiation therapy was recommended for those with aggressive histologic type and/or invasive features according to the surgeons' judgment during the operation. A median dose of 54.0 Gy (range, 44 to 60 Gy) focused on the primary tumor bed was administered to 57 patients (51.8%). RESULTS In all patients, the rates of overall survival, disease-specific survival, and disease-free survival at 10 years were 91.7%, 97.1%, and 95.8%, respectively. No significant differences in disease-specific survival (100% in the S group and 93.5% in the SRT group at 10 years, p=0.12) and disease-free survival (98.1% in the S group and 94.5% in the SRT group at 10 years, p=0.41) were observed between the treatment groups, although a significantly larger number of World Health Organization (WHO)-type B2-C (p<0.001) and Masaoka stage II (p=0.03) tumors were observed in the SRT group than in the S group. No local recurrence was observed in the SRT group. No grade 2 or greater RT-related toxicities were observed in the SRT group. CONCLUSION Excellent outcomes were achieved in patients with stage I-II TET who underwent complete resection.
Considering excellent local control and low morbidity, adjuvant RT may be considered in high risk patients with WHO-type B2-C histology and Masaoka stage II.
Citations
Citations to this article as recorded by
Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy Hyunseok Lee, Dongryul Oh, Yong Chan Ahn, Hongryull Pyo, Kyungmi Yang, Jae Myoung Noh Radiation Oncology Journal.2024; 42(1): 43. CrossRef
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma Stephen G. Chun, Andreas Rimner, Arya Amini, Joe Y. Chang, Jessica Donington, Martin J. Edelman, Yimin Geng, Matthew A. Gubens, Kristin A. Higgins, Puneeth Iyengar, Benjamin Movsas, Matthew S. Ning, Henry S. Park, George Rodrigues, Andrea Wolf, Charles B. JAMA Oncology.2023; 9(7): 971. CrossRef
Case Reports: A role of postoperative radiation therapy in completely resected early stage intrathyroid thymic carcinoma: a case report and literature review of the diagnosis and treatment Ailin Cui, Yaoqiang Du, Chunjie Hou, Lin Zhang, Litao Sun, Hongfeng He Frontiers in Oncology.2023;[Epub] CrossRef
Patterns of Failure Following Postoperative Radiation Therapy Based on “Tumor Bed With Margin” for Stage II to IV Type C Thymic Epithelial Tumor Kyung Hwa Lee, Jae Myoung Noh, Yong Chan Ahn, Dongryul Oh, Jhingook Kim, Young Mog Shim, Jung-ho Han International Journal of Radiation Oncology*Biology*Physics.2018; 102(5): 1505. CrossRef
Survival Impact of Adjuvant Radiation Therapy in Masaoka Stage II to IV Thymomas: A Systematic Review and Meta-analysis Yu Jin Lim, Eunji Kim, Hak Jae Kim, Hong-Gyun Wu, Jinchun Yan, Qin Liu, Shilpen Patel International Journal of Radiation Oncology*Biology*Physics.2016; 94(5): 1129. CrossRef
A Review of the Place and Role of Radiotherapy in Thymoma Dorothy C. Lombe, Branislav Jeremic Clinical Lung Cancer.2015; 16(6): 406. CrossRef
Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment Qian Huang, Fangwei Xie, Xuenong Ouyang The International Journal of Biological Markers.2015; 30(1): 1. CrossRef
Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck Jae Myoung Noh, Sang Yun Ha, Yong Chan Ahn, Dongryul Oh, Seung Won Seol, Young Lyun Oh, Joungho Han Cancer Research and Treatment.2014; 47(3): 436. CrossRef